Enhanced permeability across Caco-2 cell monolayers by specific mannosylating ligand of buserelin acetate proliposomes

References

• Ahn BN, Kim SK, Shim CK. (1995). Proliposomes as an intranasal dosage form for the sustained delivery of propranolol. J Control Release 34:203–10
   Web of Science ®Google Scholar
• Allen TM, Moase EH. (1996). Therapeutic opportunities for targeted liposomal drug delivery. Adv Drug Deliv Rev 21:117–33
   Web of Science ®Google Scholar
• Björkqvist B. (1981). Separation and determination of aliphatics and aromatic amines by high-performance liquid chromatography with ultraviolet detection. J Chromatogr 204:109–14
   Web of Science ®Google Scholar
• Bratt O. (2002). Hereditary prostate cancer: clinical aspects. J Urol 168:906–13
   PubMed Web of Science ®Google Scholar
• Damber JE, Aus G. (2008). Prostate cancer. Lancet 371:1710–21
   PubMed Web of Science ®Google Scholar
• Florence AT. (1997). The oral absorption of micro- and nanoparticles: neither exceptional nor unusual. Pharm Res 14:259–66
   PubMed Web of Science ®Google Scholar
• Gupta A, Sandhu RS. (1997). In vivo binding of mannose specific lectin from garlic to intestinal epithelium. Nutr Res 17:703–11
   Web of Science ®Google Scholar
• Heidenreich A, Bellmunt J, Bolla M, et al. (2011). EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59:61–71
   Google Scholar
• Hwang BY, Jung BH, Chung SJ, et al. (1997). In vitro skin permeation of nicotine from proliposomes. J Control Release 49:177–84
   Web of Science ®Google Scholar
• Iwamoto H, Yoshida A, Suzuki H, et al. (2009). A man with hypogonadotropic hypogonadism successfully treated with nasal administration of the low-dose gonadotropin-releasing hormone analog buserelin. Fertil Steril 92:1169.e1–3
   PubMedGoogle Scholar
• Jain MK, Zakim D. (1987). The spontaneous incorporation of proteins into preformed bilayers. BBA-Rev Biomembrane 906:33–68
   PubMed Web of Science ®Google Scholar
• Janga KY, Jukanti R, Velpula A, et al. (2012). Bioavailability enhancement of zaleplon via proliposomes: role of surface charge. Eur J Pharm Biopharm 80:347–57
   PubMed Web of Science ®Google Scholar
• Kawakami S, Wong J, Sato A, et al. (2000). Biodistribution characteristics of mannosylated, fucocylated, and galactocylated liposomes in mice. Biochim Biophys Acta 1524:258–65
   PubMed Web of Science ®Google Scholar
• Kimelberg HK, Papahadjopoulos D. (1971). Phospholipid–protein interactions: membrane permeability correlated with monolayer “penetration”. BBA-Biomembrane 233:805–9
   PubMed Web of Science ®Google Scholar
• Lockhoff O, Stadler P. (1998). Synthesis of glycosylamides as glycolipid analogs. Carbohyd Res 314:13–24
   Web of Science ®Google Scholar
• Ma E-L, Ma H, Liu Z, et al. (2006). In vitro and in vivo evaluation of a novel oral insulin formulation. Acta Pharmacol Sin 27:1382–8
   PubMed Web of Science ®Google Scholar
• Managit C, Kawakami S, Yamashita F, Hashida M. (2005). Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes. J Pharm Sci 94:2266–75
   PubMed Web of Science ®Google Scholar
• Meure LA, Foster NR, Dehghani F. (2008). Conventional and dense gas techniques for the production of liposomes: a review. AAPS PharmSciTech 9:798–809
   PubMed Web of Science ®Google Scholar
• Mottet N, Bellmunt J, Bolla M, et al. (2011). EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 59:572–83
   Google Scholar
• Patel G, Misra A. (2011). Chapter 10 – Oral delivery of proteins and peptides: concepts and applications. In: Ambikanandan M, ed. Challenges in delivery of therapeutic genomics and proteomics. New York, USA: Elsevier, Inc
   Google Scholar
• Pukanud P, Peungvicha P, Sarisuta N. (2009). Development of mannosylated liposomes for bioadhesive oral drug delivery via M cells of Peyer's patches. Drug Deliv 16:289–94
   PubMed Web of Science ®Google Scholar
• Rakotomanga S, Baillet A, Pellerin F, Baylocq-Ferrier D. (1992). Liquid chromatographic analysis of monosaccharides with phenylisocyanate derivatization. J Pharm Biomed Anal 10:587–91
   PubMed Web of Science ®Google Scholar
• Russell-Jones GJ. (1996). The potential use of receptor-mediated endocytosis for oral drug delivery. Adv Drug Deliv Rev 20:83–97
   Web of Science ®Google Scholar
• Russell-Jones GJ, Veitch H, Arthur L. (1999). Lectin-mediated transport of nanoparticles across Caco-2 and OK cells. Int J Pharm 190:165–74
   PubMed Web of Science ®Google Scholar
• Sanofi-Aventis Co. Ltd. (2010). Product monograph: Suprefact® buserelin acetate: Luteinizing hormone-releasing hormone (LHRH) analogue. Canada: Sanofi-Aventis Canada, Inc., 1–56
   Google Scholar
• Song KH, Chung SJ, Shim CK. (2002). Preparation and evaluation of proliposome containing salmon calcitonin. J Control Release 84:27–37
   PubMed Web of Science ®Google Scholar
• Song KH, Chung SJ, Shim CK. (2005). Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts. J Control Release 106:298–308
   PubMed Web of Science ®Google Scholar
• Takahashi K, Donovan MJ, Rogers RA, Ezekowitz RAB. (1998). Distribution of murine mannose receptor expression from early embryogenesis through to adulth hood. Cell Tissue Res 292:311–23
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Matsui Y, Sugihara H, et al. (2005). Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm 303:160–70
   PubMed Web of Science ®Google Scholar
• Tantisripreecha C, Jaturanpinyo M, Panyarachun B, Sarisuta N. (2012). Development of delayed-release proliposomes tablets for oral protein drug delivery. Drug Dev Ind Pharm 38:718–27
   PubMed Web of Science ®Google Scholar
• Torchilin VP. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145–60
   PubMed Web of Science ®Google Scholar
• Uemura K, Saka M, Nakagawa T, et al. (2002). L-MBP is expressed in epithelial cells of mouse small intestine. J Immunol 169:6945–50
   PubMed Web of Science ®Google Scholar
• Usami M, Misawa K, Yagi N, et al. (2007). Buserelin acetate microparticle dispersion effects drug release and plasma E1 levels. Int J Pharm 339:130–8
   PubMedGoogle Scholar
• Wagner S, Lynch NJ, Walter W, et al. (2003). Differential expression of the murine mannose-binding lectins A and C in lymphoid and nonlymphoid organs and tissues. J Immunol 170:1462–5
   PubMed Web of Science ®Google Scholar
• Wang B, Siahaan T, Soltero RA. (2000). Drug delivery: principles and applications. New Jersey: John Wiley & Sons, Inc
   Google Scholar
• Watzig H, Degenhardt M. (1998). Characterisation of buserelin acetate by capillary electrophoresis. J Chromatogr A 817:239–52
   Web of Science ®Google Scholar
• Witoonsaridsilp W, Paeratakul O, Panyarachun B, Sarisuta N. (2012). Development of mannosylated liposomes using synthesized N-octadecyl-d-mannopyranosylamine to enhance gastrointestinal permeability for protein delivery. AAPS PharmSciTech 13:699–706
   PubMed Web of Science ®Google Scholar
• Witoonsaridsilp W, Panyarachun B, Jaturanpinyo M, Sarisuta N. (2013). Phospholipid vesicle-bound lysozyme to enhance permeability in human intestinal cells. Pharm Dev Tech 18:821–7
   PubMed Web of Science ®Google Scholar
• Witoonsaridsilp W, Panyarachun B, Sarisuta N, Müller-Goymann CC. (2010). Influence of microenvironment and liposomal formulation on secondary structure and bilayer interaction of lysozyme. Colloid Surface B 75:501–9
   PubMed Web of Science ®Google Scholar
• Yan-yu X, Yun-mei S, Zhipeng C, Qi-neng P. (2006). Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs. Int J Pharm 319:162–8
   PubMed Web of Science ®Google Scholar
• Yeeprae W, Kawakami S, Yamashita F, Hashida M. (2006). Effect of mannose density on mannose-receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages. J Control Release 114:193–201
   PubMed Web of Science ®Google Scholar